The Indian Journal of Pediatrics

, Volume 80, Issue 10, pp 832–837 | Cite as

Outcome of Neuroblastoma in India

  • Ketan Prasad KulkarniEmail author
  • Ram Kumar Marwaha
Original Article



To assess the outcome of childhood neuroblastoma in India over the last 2 decades, identify management lacunae and suggest remedial measures.


A comprehensive search to identify literature addressing outcome of childhood neuroblastoma from India was performed. International Society of Paediatric Oncology and American Society of Clinical Oncology Annual-Meeting abstracts were hand searched to identify unpublished data. Clinico-demographic and outcome data was extracted.


Outcome of approximately 700 patients has been published over the last 2 decades with predominantly small to moderate single center series from 6 cities. Primarily non-myeloablative multiagent chemotherapy protocols alongwith surgery, have been used for treatment. A large majority of patients had stage III/IV neuroblastoma. Limited diagnostic facilities were available at most centers. Survival outcome of 8.7 to 80 % has been reported with high death and relapse rates alongwith high incomplete control/disease progression and treatment abandonment. Few series have identified prognostic parameters. Few patients with high-risk disease have been adequately treated and cured.


There is a clear need for replicating neuroblastoma outcomes at centers of excellence in other cancer centers, improving diagnostic and laboratory facilities, administering adequate and appropriate contemporary therapy, assessing disease response and improving supportive care. National data management infrastructure along with better financial and social support initiatives are key factors.


Neuroblastoma Outcome Overall survival Protocols Relapse 


Conflict of Interest


Role of Funding Source


Supplementary material

12098_2012_948_MOESM1_ESM.docx (110 kb)
ESM 1 (DOCX 110 kb)


  1. 1.
    Pizzo P, Poplack D. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2010.Google Scholar
  2. 2.
    Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with convertional chemotherapy in children older than 1 y: a 15-y experience. Indian Pediatr. 2008;45:135–9.PubMedGoogle Scholar
  4. 4.
    Rahi R, Vijyendra K, Sharma SP, et al. A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors. Indian J Urol. 2007;23:358–65.PubMedCrossRefGoogle Scholar
  5. 5.
    Kusumakumary P, Ajithkumar TV, Ratheesan K, Chellam VG, Nair MK. Pattern and outcome of neuroblastoma. A 10 y study. Indian Pediatr. 1998;35:223–9.PubMedGoogle Scholar
  6. 6.
    Kharya G, Prakash A, Dua V, et al. Clinical profile, management and outcome of neuroblastoma: a developing country experience. Pediatr Blood Cancer. 2011;57:796. abstract.Google Scholar
  7. 7.
    Kurkure P, Dhamankar V, Vora T, et al. Surviving childhood neuroblastoma: at what cost? Pediatr Blood Cancer. 2011;57:830. abstract.Google Scholar
  8. 8.
    Mandelia A, Agarwala S, Bakshi S, et al. Neuroblastoma: Outcome over a 14 y period from AIIMS NB 96 protocol. Pediatr Blood Cancer. 2011;57:755. abstract.Google Scholar
  9. 9.
    Bhatnagar S, Shastri P, Shenoy P, et al. Neuroblastomas at a pediatric cancer center in Mumbai India – Is the treatment optimal? Pediatr Blood Cancer. 2007;49:402.Google Scholar
  10. 10.
    Nandakumar A, Anantha N, Appaji L, et al. Descriptive epidemiology of childhood cancers in Bangalore. India Cancer Causes Control. 1996;7:405–10.CrossRefGoogle Scholar
  11. 11.
    Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990–2001: Incidence and survival. Int J Cancer. 2008;122:2607–11.Google Scholar
  12. 12.
    Kulkarni KP, Arora RS, Marwaha RK. Survival outcome of childhood acute lymphoblastic leukemia in India: A resource-limited perspective of more than 40 y. J Pediatr Hematol Oncol. 2011;33:475–9.Google Scholar
  13. 13.
    Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369:2106–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Katzenstein HM, Bowman LC, Brodeur GM, et al. Prognostic significance of age, MYCN, oncogene amplification, tumor cell ploidy and histology in 110 infants with stage D(S) neuroblastoma: Pediatric oncology group experience- A Pediatric Oncology Group study. J Clin Oncol. 1998;16:2007–17.Google Scholar
  15. 15.
    Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.PubMedGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2013

Authors and Affiliations

  1. 1.Division of Pediatric Hematology Oncology, Stollery Children HospitalUniversity of AlbertaEdmontonCanada
  2. 2.Division of Pediatric Hematology-OncologyAdvanced Pediatric Center, PGIMERChandigarhIndia

Personalised recommendations